Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Methods in Molecular Biology, 889 , 315324
From topical research: Most commonly reported observation: mild transient redness at application site (attributed to vascular activity from VEGF stimulation) No systemic adverse events reported in human topical studies at standard concentrations No evidence of carcinogenicity or mutagenicity in available in vitro models From injectable research (preclinical): At supratherapeutic doses in animal models, mild injection site reactions have been noted No organ toxicity observed in standard preclinical safety panels No immunogenicity concerns identified (consistent with its endogenous structure) Copper considerations: GHK-Cu delivers a small amount of bioavailable copper
[PMID: 29510201] PubMed record related to this compound for laboratory literature review
mTOR controls mitochondrial oxidative function through a YY1PGC-1 transcriptional complex
For a safer comparison, read: Are GHK-Cu Injections Safe Enough
Discussing B12 Shots & B12 Injections: Examining the Definite Relationship Between B12 Injections and Folic Acid Levels, Alongside Alternative Supplementation Options
US$ 22.62
US$ 21.22
US$ 24.16
US$ 21.84
US$ 25.65
US$ 25.59
US$ 26.78
